Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Fieber; Decompensated heart failure; Metabolic imbalance in diabetes; This is a spontaneous report received from a non-contactable physician downloaded from the regulatory Agency-WEB. The regulatory authority report number is DE-PEI-PEI2021003619. A 96-year-old male patient received second dose of bnt162b2 (COMIRNATY, Batch/Lot Number: EP9598) via an unspecified route of administration on 08Mar2021 at single dose for covid-19 immunisation. Medical history included diabetes mellitus. Historical Vaccine included first dose of bnt162b2 (COMIRNATY) on 15Feb2021 for covid-19 immunisation, and patient had been tolerated. The patient''s concomitant medications were not reported. The patient experienced fieber, decompensated heart failure, metabolic imbalance in diabetes on 13Mar2021. Events seriousness criteria was death. It was reported that 5 days after vaccination the patient developed Fever and Congestive cardiac failure and Metabolic disorder NOS, lasting for 5 days. The patient died on an unspecified date. It was not reported if an autopsy was performed. Relatedness of drug to all events assessed by PEI as Unclassifiable. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Fieber; Decompensated heart failure; Metabolic imbalance in diabetes
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166